By Linda A. Johnson / Associated Press | July 30, 2013
Pfizer and the Justice Department say the drugmaker will pay almost $491 million to resolve an investigation into illegal marketing of the company's organ transplant drug Rapamune. FULL STORY »
While much attention was given to the decision to delay the Patient Protection and Affordable Care Act's employer mandate by one year, another ACA deadline quietly arrives this week. FULL STORY »
Pfizer, in what could be the prelude to spinning off its generic drug business, said it plans to separate its commercial operations into two units, mainly for patent-protected brands and a third for generics. FULL STORY »
By Shawn Pogatchnik / Associated Press | July 29, 2013
U.S. drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion in a deal that should allow the rapidly growing company to reduce its tax bill and boost its royalty stream. FULL STORY »
Ten months after Aria Sabit arrived in Ventura, Calif., local hospital staffers noticed he suddenly developed a preference for an obscure brand of spinal implants for many of his surgeries. FULL STORY »
The world's biggest drugmakers have pledged to release detailed data about their drugs to outside researchers, a move seen by some as an effort to head off more extensive disclosure requirements. FULL STORY »
China will punish 39 hospital employees for taking illegal kickbacks from drugmakers amid a widening investigation of corruption in the country's $350 billion healthcare market. FULL STORY »
Bolstered by a high-profile legal victory at the U.S. Supreme Court this spring, the Federal Trade Commission has made the blocking of “pay-for-delay” settlements by drug companies one of its highest priorities—even reviewing older settlements to see if retroactive enforcement is... FULL STORY »
U.S. health regulators are cracking down on 15 companies for selling products they said falsely claim to cure or mitigate the symptoms of diabetes. FULL STORY »
Executives at GlaxoSmithKline were warned nearly two years ago about critical problems with the way the company conducted research at its drug development center in China. FULL STORY »
Switch to the new Modern Healthcare Daily News app
For the best experience of ModernHealthcare.com on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.
